pharma · Acute Myeloid Leukemia
Shanghai Tong Ren
Shanghai Tong Ren Hospital
Shanghai Tong Ren is a pharma organization headquartered in CN. Primary therapeutic focus areas include Acute Myeloid Leukemia. NovaPharmaNews links 1 clinical program(s), 0 drug profile(s), and 0 patent record(s) to thi
CN HQ
NMPA registrant Type
Company details
- Status
- Public
- HQ
- CN
- Programs
- 1
- Drugs
- 1
- Patents
- 0
Decitabine
Phase 2 · small molecule · Acute Myeloid Leukemia
Decitabine for Acute Myeloid Leukemia is a Phase 2 program (small_molecule) at Shanghai Tong Ren Hospital with 1 ClinicalTrials.gov record(s).
Internal code DLAAG
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Shanghai Tong Ren Hospital
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- Acute Myeloid Leukemia
- Status
- active
- Trials
- 1